Menu Menu

ENTO    Entero Therapeutics Inc    1604191    
Income Statement
Net Income -2,580,971

Balance Sheet
Current Assets 83,842,258
Assets 85,820,620
Current Liabilities 15,690,304
Liabilities 77,451,617
Equity 8,369,003
Shares Out 3,253,000

Cash Flow Statement
Operating Cash Flow -9,046,305
Investing Cash Flow 88,169

Market Analysis
Market Cap 918,106
Price 0.50
BVPS 2.57
PB 0.21
EPS -51.90
FCF -8,958,136
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec
11/13 -0.59

Find a discrepancy? The most accurate way to find company fundamental data is to view ENTO documents filed with the SEC.


ENTO Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: